How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors

Documenti analoghi

• Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions
  di: Fadini, Gian Paolo, et al.
  Pubblicazione: (2018)
• It Is All in the Blood: The Multifaceted Contribution of Circulating Progenitor Cells in Diabetic Complications
  di: Fadini, Gian Paolo, et al.
  Pubblicazione: (2012)
• Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
  di: Longato, Enrico, et al.
  Pubblicazione: (2020)
• The pleiotropic cardiovascular effects of dipeptidyl peptidase‐4 inhibitors
  di: Avogaro, Angelo, et al.
  Pubblicazione: (2018)
• Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study
  di: Fadini, Gian Paolo, et al.
  Pubblicazione: (2018)